---
title: 谷歌 DeepMind 推出用于活细胞的 AI 模型
date: 2024-05-08T15:00:07.491Z
description: AlphaFold 3 aims to reveal biological secrets and boost drug search efforts
tags: 
- Anjana Ahuja
author: ft
---

[原文链接](https://ft.com/content/77bf38b7-114d-44c8-956e-1e39e39ecb52)

# **谷歌 DeepMind** 推出用于活细胞的 **AI** 模型

**谷歌 DeepMind** 揭晓了其在 **人工智能** 领域的最新进展——**AlphaFold 3**，这是其突破性技术的第三个迭代版本。这个新模型专注于生命的基本构建块及其在 **细胞** 内的复杂相互作用，旨在揭开 **疾病** 如 **癌症** 的秘密，并加速有效治疗方法的发现。

**AlphaFold 3** 在一份《**自然**》论文中公布，代表了预测 **生物分子** 的结构和行为方面的一项重大进步，包括 **蛋白质**、**DNA**、**RNA** 和 **配体**。通过理解这些分子及其复杂的相互关系，科学家可以洞察细胞内部的工作机制，并确定潜在的药物开发靶标。

**AlphaFold 3** 的一个关键优势是它能够大幅减少药物发现所需的时间。据 **Isomorphic Labs**（DeepMind 的一个衍生公司）的 Max Jaderberg 称，该模型使科学家能够 "在原子水平上创建和测试假设"，并在几秒钟内获得高度准确的结构预测，而传统上这需要数月或数年的实验工作。

该模型还展示了优于现有专业工具的预测准确性，突显了 **AI 深层学习框架** 在减少有意义的生物洞察力所需的数据量方面的潜力。**DeepMind** 的 **AlphaFold** 团队负责人 **John Jumper** 强调了此技术在 **植物生物学** 和粮食安全等领域的潜在影响。

虽然 **AlphaFold 3** 提供了令人兴奋的可能性，但 DeepMind 承认需要对其预测进行实验验证。该公司正将模型的大部分功能免费提供给学术界非商业用户，以促进科学界进一步的探索和合作。

**波士顿咨询集团** 最近的一项研究强调了 **AI** 在药物发现中的影响，该研究表明，由人工智能发现的药物在早期试验中的成功率更高。该研究谨慎乐观地认为，人工智能可以革命性地提高制药研究和开发的生产力。**AlphaFold 3** 凭借其先进的能力和可访问性，有望在此变革之旅中发挥关键作用。

---

# Google DeepMind Unveils AI Model for Living Cells 

**Google DeepMind** has revealed its latest advancement in **artificial intelligence** with the introduction of **AlphaFold 3**, the third iteration of its groundbreaking technology. This new model focuses on the fundamental building blocks of life and their intricate interactions within **cells**, aiming to unlock the secrets of **diseases** such as **cancer** and accelerate the discovery of effective treatments. 

/n/n

AlphaFold 3, detailed in a **Nature** paper, represents a significant leap forward in predicting the structure and behavior of **biological molecules**, including **proteins**, **DNA**, **RNA**, and **ligands**. By understanding these molecules and their complex relationships, scientists can gain insights into the inner workings of cells and identify potential targets for drug development. 

/n/n

A key advantage of AlphaFold 3 is its ability to drastically reduce the time required for drug discovery. According to Max Jaderberg of **Isomorphic Labs**, a DeepMind spin-off, the model enables scientists to "create and test hypotheses at the atomic level" and obtain highly accurate structure predictions in a matter of seconds, a process that traditionally takes months or years of experimental work. 

/n/n

The model also showcases improved predictive accuracy over existing specialized tools, highlighting the potential of **AI deep learning frameworks** in minimizing the data requirements for meaningful biological insights. **John Jumper**, DeepMind's AlphaFold team leader, emphasized the technique's potential impact on fields like **plant biology** and food security. 

/n/n

While AlphaFold 3 offers exciting possibilities, DeepMind acknowledges the need for experimental validation of its predictions. The company is making the majority of the model's functionality freely accessible to academic non-commercial users, fostering further exploration and collaboration in the scientific community. 

/n/n

The impact of AI in drug discovery is highlighted by a recent **Boston Consulting Group** study, which suggests that AI-discovered drugs have higher success rates in early-stage trials. The study cautiously optimizes that AI could revolutionize the productivity of pharmaceutical research and development. AlphaFold 3, with its advanced capabilities and accessibility, is poised to play a pivotal role in this transformative journey.

[Source Link](https://ft.com/content/77bf38b7-114d-44c8-956e-1e39e39ecb52)

